Impact of G-CSF prophylaxis on the occurrence of neutropenia in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel.
Authors:
- M. OzgurogluMOM. Ozguroglu
- S. OudardSOS. Oudard
- A. O. SartorASA. O. Sartor
- S. HansenSHS. Hansen
- J. H. MachielsJMJ. H. Machiels
- L. ShenLSL. Shen
- J. S. De BonoJBJ. S. De Bono
- For the TROPIC investigatorsFIFor the TROPIC investigators
- 20 May 2011
- journal article
- genitourinary cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (15_suppl) , e15131